RÉSUMÉ
Based on the indicator function integral, this paper identifies the displacement of oil storage tank and calibrates the tank capacity table model. The displacement parameters of a cylinder oil tank with spherical caps at both ends are deduced by establishing an appropriate rectangular coordinate system while cross-section analysis, coordinate transformation, and the functional relationship between oil reserves and oil level height are used as well. Furthermore, the displacement parameters are determined by the least square method and alternating contraction search method to verify the data, which improves the accuracy of the calculation. This research simplifies the integral operation and can be extended to other types of liquid containers of arbitrary shape as a generally applicable method, which shows significant application value for further research on the integral method of indicator function.
RÉSUMÉ
Glioblastoma, the most lethal primary brain tumor, harbors glioma stem cells (GSCs) that not only initiate and maintain malignant phenotypes but also enhance therapeutic resistance. Although frequently mutated in glioblastomas, the function and regulation of PTEN in PTEN-intact GSCs are unknown. Here, we found that PTEN directly interacted with MMS19 and competitively disrupted MMS19-based cytosolic iron-sulfur (Fe-S) cluster assembly (CIA) machinery in differentiated glioma cells. PTEN was specifically succinated at cysteine (C) 211 in GSCs compared with matched differentiated glioma cells. Isotope tracing coupled with mass spectrometry analysis confirmed that fumarate, generated by adenylosuccinate lyase (ADSL) in the de novo purine synthesis pathway that is highly activated in GSCs, promoted PTEN C211 succination. This modification abrogated the interaction between PTEN and MMS19, reactivating the CIA machinery pathway in GSCs. Functionally, inhibiting PTEN C211 succination by reexpressing a PTEN C211S mutant, depleting ADSL by shRNAs, or consuming fumarate by the US Food and Drug Administration-approved prescription drug N-acetylcysteine (NAC) impaired GSC maintenance. Reexpressing PTEN C211S or treating with NAC sensitized GSC-derived brain tumors to temozolomide and irradiation, the standard-of-care treatments for patients with glioblastoma, by slowing CIA machinery-mediated DNA damage repair. These findings reveal an immediately practicable strategy to target GSCs to treat glioblastoma by combination therapy with repurposed NAC.
Sujet(s)
Tumeurs du cerveau , Glioblastome , Gliome , Humains , Glioblastome/traitement médicamenteux , Fer/métabolisme , Gliome/traitement médicamenteux , Tumeurs du cerveau/traitement médicamenteux , Cellules souches tumorales/anatomopathologie , Soufre/métabolisme , Soufre/usage thérapeutique , Fumarates , Lignée cellulaire tumorale , Phosphohydrolase PTEN/métabolismeRÉSUMÉ
As Asia is the most populous continent in the world, the contradiction between water supply and demand is increasing. Wastewater treatment and reclaimed water use are important means to solve the contradiction between supply and demand and realize the sustainability of the water management system. Based on the data collected from 48 typical countries and regions in Asia, this study evaluates the possible influential factors on wastewater treatment and reclaimed water use such as Gross Domestic Product (GDP) level, water resource availability, water withdrawn and water stress. It is identified that per capita GDP and water stress are important factors affecting wastewater treatment and reclaimed water use. Although reclaimed water use in most Asian countries is still at the early stage, the development of wastewater treatment is conducive to the development of reclaimed water. The results of this study are believed to be useful in improving water management and sustainability levels in Asian countries.
Sujet(s)
Conservation des ressources naturelles , Purification de l'eau , Asie , Élimination des déchets liquides , Eaux usées , Alimentation en eauRÉSUMÉ
[This corrects the article DOI: 10.1155/2018/3176893.].
RÉSUMÉ
We consider a class of viral infection dynamic models with inhibitory effect on the growth of uninfected T cells caused by infected T cells and logistic target cell growth. The basic reproduction number R 0 is derived. It is shown that the uninfected equilibrium is globally asymptotically stable if R 0 < 1. Sufficient conditions for the existence of Hopf bifurcation at the infected equilibrium are investigated by analyzing the distribution of eigenvalues. Furthermore, the properties of Hopf bifurcation are determined by the normal form theory and the center manifold. Numerical simulations are carried out to support the theoretical analysis.
Sujet(s)
Taux de reproduction de base , Lymphocytes T/physiologie , Algorithmes , Prolifération cellulaire , Biologie informatique , Simulation numérique , Infections à VIH/virologie , VIH-1 (Virus de l'Immunodéficience Humaine de type 1) , Humains , Modèles biologiques , Lymphocytes T/virologie , Facteurs temps , Maladies virales/sangRÉSUMÉ
Mitochondrial production of reactive oxygen species and oxidation of cardiolipin are key events in initiating apoptosis. We reported that group VIA Ca(2+)-independent phospholipase A(2) (iPLA(2)beta) localizes in and protects beta-cell mitochondria from oxidative damage during staurosporine-induced apoptosis. Here, we used iPLA(2)beta-null (iPLA(2)beta(-/-)) mice to investigate the role of iPLA(2)beta in the repair of mitochondrial membranes. We show that islets isolated from iPLA(2)beta(-/-) mice are more sensitive to staurosporine-induced apoptosis than those from wild-type littermates and that 2 wk of daily ip administration of staurosporine to iPLA(2)beta(-/-) mice impairs both the animals' glucose tolerance and glucose-stimulated insulin secretion by their pancreatic islets. Moreover, the iPLA(2)beta inhibitor bromoenol lactone caused mitochondrial membrane peroxidation and cytochrome c release, and these effects were reversed by N-acetyl cysteine. The mitochondrial antioxidant N-t-butyl hydroxylamine blocked staurosporine-induced cytochrome c release and caspase-3 activation in iPLA(2)beta(-/-) islets. Furthermore, the collapse of mitochondrial membrane potential in INS-1 insulinoma cells caused by high glucose and fatty acid levels was attenuated by overexpressing iPLA(2)beta. Interestingly, iPLA(2)beta was expressed only at low levels in islet beta-cells from obesity- and diabetes-prone db/db mice. These findings support the hypothesis that iPLA(2)beta is important in repairing oxidized mitochondrial membrane components (e.g. cardiolipin) and that this prevents cytochrome c release in response to stimuli that otherwise induce apoptosis. The low iPLA(2)beta expression level in db/db mouse beta-cells may render them vulnerable to injury by reactive oxygen species.
Sujet(s)
Group VI Phospholipases A2/métabolisme , Cellules à insuline/métabolisme , Membranes mitochondriales/métabolisme , Animaux , Apoptose , Technique de Western , Cardiolipides/métabolisme , Caspase-3/métabolisme , Cellules cultivées , Cytochromes c/métabolisme , Glucose/pharmacologie , Hyperglycémie provoquée , Group VI Phospholipases A2/génétique , Immunohistochimie , Insuline/métabolisme , Cellules à insuline/effets des médicaments et des substances chimiques , Ilots pancréatiques/effets des médicaments et des substances chimiques , Ilots pancréatiques/métabolisme , Peroxydation lipidique/effets des médicaments et des substances chimiques , Potentiel de membrane mitochondriale/effets des médicaments et des substances chimiques , Souris , Souris knockout , Membranes mitochondriales/effets des médicaments et des substances chimiques , Acide palmitique/pharmacologie , Phospholipides/métabolisme , Répartition aléatoire , Staurosporine/pharmacologieRÉSUMÉ
OBJECTIVE: To assess the role of calcium-independent phospholipase A2 (iPLA2) in human pancreatic islets. METHODS: The immunohistochemical analysis and Western blot were employed to examine iPLA2 expression in human pancreatic islets. Bromoenol lactone (BEL), a selective inhibitor of iPLA2, was used in a randomized controlled trial to compare its influence to glucose-stimulated insulin secretion. RESULTS: iPLA2 was expressed predominantly in islet cells co-stained by insulin but was barely detected in the exocrine acinar cells. Western blot results indicated that islet cells expressed an iPLA2-immunoreactive band at the 80 kDa region. Glucose-stimulated insulin secretory response was dramatically reduced in islets pretreated with BEL (0.8285 +/- 0.0803 ng x islet(-1) x h(-1)) as compared with the control (1.2264 +/- 0.0568 ng x islet(-1) x h(-1)) (P < 0.01). BEL inhibited glucose stimulated insulin secretion from isolated human islets. CONCLUSION: iPLA2 signaling plays an important role in glucose-stimulated insulin secretion under the physiological conditions.
Sujet(s)
Insuline/biosynthèse , Ilots pancréatiques/métabolisme , Calcium-independent phospholipase A2/métabolisme , Lignée cellulaire , Glucose/métabolisme , Humains , Naphtalènes/pharmacologie , Pyrones/pharmacologie , Transduction du signalRÉSUMÉ
Mitochondria-mediated production of reactive oxygen species (ROS) plays a key role in apoptosis. Mitochondrial phospholipid cardiolipin molecules are likely the main target of ROS because they are particularly rich in polyunsaturated fatty acids. They are also located in the inner mitochondrial membrane near the ROS-producing sites. Under physiological conditions mitochondria can repair peroxidative damage in part through a remodeling mechanism via the deacylation-reacylation cycle mediated by phospholipase A2 (PLA2) and acyl-coenzyme A-dependent monolysocardiolipin acyltransferase. Here we investigate whether group VIA Ca2+-independent PLA2 (iPLA2) plays a role in the protection of mitochondrial function from damage caused by mitochondrially generated ROS during apoptotic induction by staurosporine (STS). We show that iPLA2-expressing cells were relatively resistant to STS-induced apoptosis. iPLA2 localized to mitochondria even before apoptotic induction, and most iPLA2-associated mitochondria were intact in apoptotic resistant cells. Expression of iPLA2 in INS-1 cells prevented the loss of mitochondrial membrane potential, attenuated the release of cytochrome c, Smac/DIABLO, and apoptosis inducing factor from mitochondria, and reduced mitochondrial reactive oxygen species production. Inhibition of caspase 8 has little effect on STS-induced apoptosis in INS-1 cells. Finally, we found that STS down-regulated endogenous iPLA2 transcription in both INS-1 and iPLA2-expressing INS-1 cells without affecting the expression of group IV Ca2+-dependent PLA2. Together, our data indicate that iPLA2 is important for the protection of mitochondrial function from oxidative damage during apoptotic induction. Down-regulation of endogenous iPLA2 by STS may result in the loss of mitochondrial membrane repair functions and lead to mitochondrial failure and apoptosis.
Sujet(s)
Apoptose , Mitochondries/métabolisme , Phospholipases A/physiologie , Staurosporine/pharmacologie , Animaux , Apoptose/effets des médicaments et des substances chimiques , Caspases/métabolisme , Lignée cellulaire , Group VI Phospholipases A2 , Membranes intracellulaires , Cinétique , Potentiels de membrane , Phospholipases A/génétique , Phospholipases A/métabolisme , Phospholipases A2 , Espèces réactives de l'oxygène/métabolisme , Superoxydes , Transcription génétique/effets des médicaments et des substances chimiquesRÉSUMÉ
The G1 phase of the cell cycle is characterized by a high rate of membrane phospholipid turnover. Cells regulate this turnover by coordinating the opposing actions of CTP:phosphocholine cytidylyltransferase and the group VI Ca2+-independent phospholipase A2 (iPLA2). However, little is known about how such turnover affects cell-cycle progression. Here, we show that G1-phase phospholipid turnover is essential for cell proliferation. Specific inhibition of iPLA2 arrested cells in the G1 phase of the cell cycle. This G1-phase arrest was associated with marked upregulation of the tumour suppressor p53 and the expression of cyclin-dependent kinase inhibitor p21cip1. Inactivation of iPLA2 failed to arrest p53-deficient HCT cells in the G1 phase and caused massive apoptosis of p21-deficient HCT cells, suggesting that this G1-phase arrest requires activation of p53 and expression of p21cip1. Furthermore, downregulation of p53 by siRNA in p21-deficient HCT cells reduced the cell death, indicating that inhibition of iPLA2 induced p53-dependent apoptosis in the absence of p21cip1. Thus, our study reveals hitherto unrecognized cooperation between p53 and iPLA2 to monitor membrane-phospholipid turnover in G1 phase. Disrupting the G1-phase phospholipid turnover by inhibition of iPLA2 activates the p53-p21cip1 checkpoint mechanism, thereby blocking the entry of G1-phase cells into S phase.
Sujet(s)
Phase G1/physiologie , Phospholipases A/physiologie , Protéine p53 suppresseur de tumeur/physiologie , Cycle cellulaire/effets des médicaments et des substances chimiques , Cycle cellulaire/physiologie , Mort cellulaire/physiologie , Inhibiteur p21 de kinase cycline-dépendante/biosynthèse , Phase G1/effets des médicaments et des substances chimiques , Régulation de l'expression des gènes , Group VI Phospholipases A2 , Humains , Naphtalènes/pharmacologie , Nocodazole/pharmacologie , Inhibiteurs de la phosphodiestérase/pharmacologie , Phospholipases A/antagonistes et inhibiteurs , Phospholipases A2 , Phospholipides/métabolisme , Pyrones/pharmacologieRÉSUMÉ
OBJECTIVE: To investigate the efferent pathway from the dorsal raphe nucleus to the inner ear. METHODS: Eleven adult cats weighing 2.0 - 3.0 kg were used. The animals had no middle-ear disease and their auricle reflex was sensitive to sound. They were divided into experimental group (8 cats) and control group (3 cases). The fluorescent tracer cholera toxin subunit-B (CTB) was injected into cat cochlea and the CTB-labelled neurons of dorsal raphe nucleus (DRN) were identified using an immunofluorescence technique after a survival period of 7 days. For studying other fluorescence labelling, the sections containing CTB-labelled neurons were divided into four groups and incubated in antisera directed against tyrosine hydroxylase (TH), serotonin (5-HT), gamma-aminobutyric acid (GABA) and dopamine B-hydroxylase (DBH), respectively. Single-and double-labelled neurons were identified from the DRN. RESULTS: (1) A subpopulation of dorsal raphe nucleus (DRN) neurons were intensely labelled with CTB and these CTB-labelled neurons were densely distributed in a dorsomedial part of the DRN; (2) Four immunolabelling, TH, 5-HT, GABA and DBH were presented throughout the DRN. Of the total population of CTB-labelled neurons, 100% were TH-labelled neurons (double labelling) and no double-stained neuron with 5-HT, GABA and DBH was observed in the DRN. CONCLUSIONS: There was a projection from DRN to the inner ear and this pathway might be a dopaminergic projection.
Sujet(s)
Oreille interne/innervation , Neurones/physiologie , Noyaux du raphé/physiologie , Animaux , Chats , Oreille interne/métabolisme , Voies efférentes , Neurones/métabolisme , Noyaux du raphé/métabolismeRÉSUMÉ
Dietary advanced glycosylation end products (AGEs) have been linked to insulin resistance in db/db(++) mice. To test whether dietary AGEs play a role in the progression of insulin resistance in normal mice fed high-fat diets, normal C57/BL6 mice were randomly assigned to high-fat diets (35% g fat), either high (HAGE-HF group; 995.4 units/mg AGE) or low (by 2.4-fold LAGE-HF group; 329.6 units/mg AGE) in AGE content for 6 months. Age-matched C57/BL6 and db/db(++) mice fed regular diet (5% g fat, 117.4 units/mg AGE) served as controls. After 6 months, 75% of HAGE-HF mice were diabetic and exhibited higher body weight (P < 0.001), fasting glucose (P < 0.001), insulin (P < 0.001), and serum AGEs (P < 0.01) than control mice, while none of the LAGE-HF mice were diabetic despite a similar rise in body weight and plasma lipids. The HAGE-HF group displayed markedly impaired glucose and insulin responses during glucose tolerance tests and euglycemic and hyperglycemic clamps and altered pancreatic islet structure and function compared with those of LAGE-HF mice, in which findings resembled those of control mice. The HAGE-HF group had more visceral fat (by two- and fourfold) and more AGE-modified fat (by two- and fivefold) than LAGE-HF and control mice, respectively. In the HAGE-HF group, plasma 8-isoprostane was higher (P < 0.01) and adiponectin lower (P < 0.001) than control mice, while in the LAGE-HF group, these were more modestly affected (P < 0.05). These results demonstrate that the development of insulin resistance and type 2 diabetes during prolonged high-fat feeding are linked to the excess AGEs/advanced lipoxidation end products inherent in fatty diets.
Sujet(s)
Diabète de type 2/étiologie , Matières grasses alimentaires/administration et posologie , Produits terminaux de glycation avancée/administration et posologie , Insulinorésistance , Adiponectine , Tissu adipeux/composition chimique , Animaux , Glycémie/analyse , Poids , Dinoprost/analogues et dérivés , Dinoprost/sang , Jeûne , Femelle , Technique du clamp glycémique , Hyperglycémie provoquée , Produits terminaux de glycation avancée/analyse , Produits terminaux de glycation avancée/sang , Hyperplasie , Insuline/sang , Protéines et peptides de signalisation intercellulaire/sang , Ilots pancréatiques/anatomopathologie , Lipides/sang , Souris , Souris de lignée C57BLRÉSUMÉ
Islet Ca2+-independent phospholipase A2 (iPLA2) is postulated to mediate insulin secretion by releasing arachidonic acid in response to insulin secretagogues. However, the significance of iPLA2 signaling in insulin secretion in vivo remains unexplored. Here we investigated the physiological role of iPLA2 in beta-cell lines, isolated islets, and mice. We showed that small interfering RNA-specific silencing of iPLA2 expression in INS-1 cells significantly reduced insulin-secretory responses of INS-1 cells to glucose. Immunohistochemical analysis revealed that mouse islet cells expressed significantly higher levels of iPLA2 than pancreatic exocrine acinar cells. Bromoenol lactone (BEL), a selective inhibitor of iPLA2, inhibited glucose-stimulated insulin secretion from isolated mouse islets; this inhibition was overcome by exogenous arachidonic acid. We also showed that iv BEL administration to mice resulted in sustained hyperglycemia and reduced insulin levels during glucose tolerance tests. Clamp experiments demonstrated that the impaired glucose tolerance was due to insufficient insulin secretion rather than decreased insulin sensitivity. Short-term administration of BEL to mice had no effect on fasting glucose levels and caused no apparent pathological changes of islets in pancreas sections. These results unambiguously demonstrate that iPLA2 signaling plays an important role in glucose-stimulated insulin secretion under physiological conditions.
Sujet(s)
Glucose/métabolisme , Insuline/métabolisme , Phospholipases A/antagonistes et inhibiteurs , Phospholipases A/métabolisme , Animaux , Technique de Western , Lignée cellulaire , Extinction de l'expression des gènes , Hyperglycémie provoquée , Group VI Phospholipases A2 , Immunohistochimie , Sécrétion d'insuline , Ilots pancréatiques/cytologie , Ilots pancréatiques/métabolisme , Mâle , Souris , Souris de lignée C57BL , Naphtalènes/pharmacologie , Techniques de patch-clamp , Phospholipases A2 , Pyrones/pharmacologie , ARN/métabolisme , Petit ARN interférent/métabolisme , Transduction du signal , Facteurs temps , TransfectionRÉSUMÉ
Successful islet transplantation depends on the infusion of sufficiently large quantities of islets, of which only approximately 30% become stably engrafted. Rapid and adequate revascularization of transplanted islets is important for islet survival and function. Delayed and insufficient revascularization can deprive islets of oxygen and nutrients, resulting in islet cell death and early graft failure. To improve islet revascularization, we delivered human vascular endothelial growth factor (VEGF) cDNA to murine islets, followed by transplantation under the renal capsule in diabetic mice. Diabetic animals receiving a marginal mass of 300 islets that were pretransduced with a VEGF vector exhibited near normoglycemia. In contrast, diabetic mice receiving an equivalent number of islets that were transduced with a control vector remained hyperglycemic. Immunohistochemistry with anti-insulin and anti-CD31 antibodies revealed a relatively higher insulin content and greater degree of microvasculature in the VEGF vector-transduced islet grafts, which correlated with significantly improved blood glucose profiles and enhanced insulin secretion in response to glucose challenge in this group of diabetic recipient mice. These results demonstrate that VEGF production in islets stimulates graft angiogenesis and enhances islet revascularization. This mechanism might be explored as a novel strategy to accelerate islet revascularization and improve long-term survival of functional islet mass posttransplantation.